Optional Sub-study to Intraoperative Imaging With ICG Registry



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:9/14/2018
Start Date:December 2015
Contact:Sunil Singhal, MD, Ph.D
Email:PennCancerTrials@emergingmed.com
Phone:855-216-0098

Use our guide to learn which trials are right for you!

The primary goal of this optional sub-study is to record what tissues fluoresce in the
operating room, and then to identify if these lesions are cancer when the histopathology is
performed.


Inclusion Criteria:

- Adult patients >= 18 years of age

- Patients presenting with any solid tumor and/or diseased tissue even benign nodules
presumed to be resectable and are at risk for recurrence.

- Good operative candidate as determined by the treating physician and/or
multidisciplinary team

- Subject capable of giving informed consent and participating in the process of
consent.

Exclusion Criteria:

- Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery

- Vulnerable patient populations
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Sunil Singhal, MD, PhD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials